• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infection A Simple Algorithm Helps Early Identification of SARS-CoV-2 Infection Patients With Severe Progression Tendency

tetano

Editor, Senior Moderator
Infection


. 2020 May 21.
doi: 10.1007/s15010-020-01446-z. Online ahead of print.
A Simple Algorithm Helps Early Identification of SARS-CoV-2 Infection Patients With Severe Progression Tendency


Qiang Li[SUP] 1 [/SUP], Jianliang Zhang[SUP] 1 [/SUP], Yun Ling[SUP] 2 [/SUP], Weixia Li[SUP] 2 [/SUP], Xiaoyu Zhang[SUP] 1 [/SUP], Hongzhou Lu[SUP] 3 [/SUP], Liang Chen[SUP] 4 [/SUP]



Affiliations

Abstract

Objectives: We aimed to develop a simple algorithm to help early identification of SARS-CoV-2 infection patients with severe progression tendency.
Methods: The univariable and multivariable analysis were computed to identify the independent predictors of COVID-19 progression. The prediction model was established in a retrospective training set of 322 COVID-19 patients and was re-evaluated in a prospective validation set of 317 COVID-19 patients.
Results: The multivariable analysis identified age (OR = 1.061, p = 0.028), lactate dehydrogenase (LDH) (OR = 1.006, p = 0.037), and CD4 count (OR = 0.993, p = 0.006) as the independent predictors of COVID-19 progression. Consequently, the age-LDH-CD4 algorithm was derived as (age ? LDH)/CD4 count. In the training set, the area under the ROC curve (AUROC) of age-LDH-CD4 model was significantly higher than that of single CD4 count, LDH, or age (0.92, 0.85, 0.80, and 0.75, respectively). In the prospective validation set, the AUROC of age-LDH-CD4 model was also significantly higher than that of single CD4 count, LDH, or age (0.92, 0.75, 0.81, and 0.82, respectively). The age-LDH-CD4 ≥ 82 has high sensitive (81%) and specific (93%) for the early identification of COVID-19 patients with severe progression tendency.
Conclusions: The age-LDH-CD4 model is a simple algorithm for early identifying patients with severe progression tendency following SARS-CoV-2 infection, and warrants further validation.

Keywords: 2019 novel coronavirus disease; Risk factors; Severe acute respiratory syndrome coronavirus 2; Severe progression.
 
Back
Top Bottom